These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model. Lee DJ; Lyshchik A; Huamani J; Hallahan DE; Fleischer AC J Ultrasound Med; 2008 Jun; 27(6):855-66. PubMed ID: 18499845 [TBL] [Abstract][Full Text] [Related]
4. VEGFR2-Targeted Contrast-Enhanced Ultrasound to Distinguish between Two Anti-Angiogenic Treatments. Payen T; Dizeux A; Baldini C; Le Guillou-Buffello D; Lamuraglia M; Comperat E; Lucidarme O; Bridal SL Ultrasound Med Biol; 2015 Aug; 41(8):2202-11. PubMed ID: 25980323 [TBL] [Abstract][Full Text] [Related]
5. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339 [TBL] [Abstract][Full Text] [Related]
6. Molecular imaging of vulnerable plaques in rabbits using contrast-enhanced ultrasound targeting to vascular endothelial growth factor receptor-2. Liu H; Wang X; Tan KB; Liu P; Zhuo ZX; Liu Z; Hua X; Zhuo QQ; Xia HM; Gao YH J Clin Ultrasound; 2011 Feb; 39(2):83-90. PubMed ID: 21213333 [TBL] [Abstract][Full Text] [Related]
7. Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent. Abou-Elkacem L; Wilson KE; Johnson SM; Chowdhury SM; Bachawal S; Hackel BJ; Tian L; Willmann JK Theranostics; 2016; 6(11):1740-52. PubMed ID: 27570547 [TBL] [Abstract][Full Text] [Related]
8. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118 [TBL] [Abstract][Full Text] [Related]
9. Preparation and Imaging Investigation of Dual-targeted C Du J; Li XY; Hu H; Xu L; Yang SP; Li FH Sci Rep; 2018 Mar; 8(1):3887. PubMed ID: 29497045 [TBL] [Abstract][Full Text] [Related]
10. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer. Wang H; Kaneko OF; Tian L; Hristov D; Willmann JK Invest Radiol; 2015 May; 50(5):322-9. PubMed ID: 25575176 [TBL] [Abstract][Full Text] [Related]
11. VEGFR2-targeted molecular imaging in the mouse embryo: an alternative to the tumor model. Denbeigh JM; Nixon BA; Hudson JM; Puri MC; Foster FS Ultrasound Med Biol; 2014 Feb; 40(2):389-99. PubMed ID: 24342913 [TBL] [Abstract][Full Text] [Related]
12. In vivo targeted contrast enhanced micro-ultrasound to measure intratumor perfusion and vascular endothelial growth factor receptor 2 expression in a mouse orthotopic bladder cancer model. Chan ES; Patel AR; Larchian WA; Heston WD J Urol; 2011 Jun; 185(6):2359-65. PubMed ID: 21511281 [TBL] [Abstract][Full Text] [Related]
13. Molecular ultrasound imaging using contrast agents targeting endoglin, vascular endothelial growth factor receptor 2 and integrin. Leguerney I; Scoazec JY; Gadot N; Robin N; Pénault-Llorca F; Victorin S; Lassau N Ultrasound Med Biol; 2015 Jan; 41(1):197-207. PubMed ID: 25308938 [TBL] [Abstract][Full Text] [Related]
14. Quantification of Endothelial αvβ3 Expression with High-Frequency Ultrasound and Targeted Microbubbles: In Vitro and In Vivo Studies. Daeichin V; Kooiman K; Skachkov I; Bosch JG; Theelen TL; Steiger K; Needles A; Janssen BJ; Daemen MJ; van der Steen AF; de Jong N; Sluimer JC Ultrasound Med Biol; 2016 Sep; 42(9):2283-93. PubMed ID: 27302657 [TBL] [Abstract][Full Text] [Related]
15. Ultrasound Molecular Imaging of Neovascularization for Evaluation of Endometrial Receptivity Using Magnetic iRGD-Modified Lipid-Polymer Hybrid Microbubbles. He Y; Zhou M; Li S; Gong Z; Yan F; Liu H Int J Nanomedicine; 2022; 17():5869-5881. PubMed ID: 36483520 [TBL] [Abstract][Full Text] [Related]
16. [Detection of binding capability of targeted KDR ultrasound contrast agent in vitro for evaluating endometrial receptivity]. Liu H; Han X; Yang L; Ji L; Li S Nan Fang Yi Ke Da Xue Xue Bao; 2013 Sep; 33(9):1308-11. PubMed ID: 24067209 [TBL] [Abstract][Full Text] [Related]
17. Effects of low-frequency ultrasound and microbubbles on angiogenesis-associated proteins in subcutaneous tumors of nude mice. Shen ZY; Shen E; Zhang JZ; Bai WK; Wang Y; Yang SL; Nan SL; Lin YD; Li Y; Hu B Oncol Rep; 2013 Aug; 30(2):842-50. PubMed ID: 23707983 [TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor receptor type 2-targeted contrast-enhanced US of pancreatic cancer neovasculature in a genetically engineered mouse model: potential for earlier detection. Pysz MA; Machtaler SB; Seeley ES; Lee JJ; Brentnall TA; Rosenberg J; Tranquart F; Willmann JK Radiology; 2015 Mar; 274(3):790-9. PubMed ID: 25322341 [TBL] [Abstract][Full Text] [Related]
19. Quantification of bound microbubbles in ultrasound molecular imaging. Daeichin V; Akkus Z; Skachkov I; Kooiman K; Needles A; Sluimer J; Janssen B; Daemen MJ; van der Steen AF; de Jong N; Bosch JG IEEE Trans Ultrason Ferroelectr Freq Control; 2015 Jun; 62(6):1190-200. PubMed ID: 26067053 [TBL] [Abstract][Full Text] [Related]
20. Detection of Mice Colorectal Tumors by Endoluminal Ultrasound Biomicroscopic Images and Quantification of Image Augmented Gray Values Following Injection of VEGFR-2 Targeted Contrast Agent. Soletti RC; de Britto MAP; Borges HL; Machado JC Acad Radiol; 2021 Jun; 28(6):808-816. PubMed ID: 32067837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]